Ignite Creation Date:
2024-05-05 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00529698
Status:
COMPLETED
Last Update Posted:
2011-03-01
First Post:
2007-09-13
Brief Title:
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Sponsor:
Istituto Superiore di Sanità
Organization:
Istituto Superiore di Sanità
Organization Data
Organization:
Istituto Superiore di Sanità
Class:
OTHER
Study ID:
ISSP-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istituto Superiore di Sanità
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Barbara Ensoli MD Phd
Old Organization:
Istituto Superiore di Sanita